Axogen Free Cash Flow (FCF) History (AXGN)
Axogen reported −$2.9M in free cash flow for fiscal 2025, a decrease of $4.4M from the previous fiscal year, with a free cash flow margin of −1.30%.
View full Axogen company overviewAxogen free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.9M | −$4.4M | — | −1.30% |
| 2024 | 2024-12-31 | $1.4M | $21.0M | — | +0.77% |
| 2023 | 2023-12-31 | −$19.6M | $16.6M | — | −12.32% |
| 2022 | 2022-12-31 | −$36.1M | $5.1M | — | −26.08% |
| 2021 | 2021-12-31 | −$41.2M | −$9.7M | — | −32.36% |
| 2020 | 2020-12-31 | −$31.5M | −$7.0M | — | −28.08% |
| 2019 | 2019-12-31 | −$24.5M | −$392,000 | — | −22.99% |
| 2018 | 2018-12-31 | −$24.1M | −$13.8M | — | −28.76% |
| 2017 | 2017-12-31 | −$10.3M | $1.8M | — | −17.12% |
| 2016 | 2016-12-31 | −$12.2M | $1.3M | — | −29.60% |
| 2015 | 2015-12-31 | −$13.5M | −$2.5M | — | −49.25% |
| 2014 | 2014-12-31 | −$11.0M | −$369,570 | — | −65.37% |
| 2013 | 2013-12-31 | −$10.6M | −$1.9M | — | −97.04% |
| 2012 | 2012-12-31 | −$8.7M | −$1.6M | — | −113.24% |
| 2011 | 2011-12-31 | −$7.1M | — | — | −146.41% |
Axogen quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.3M | −$680,000 | −9.70% | +9.07% |
| Q1 2026 | 2026-03-31 | −$1.2M | $12.2M | — | −1.99% |
| Q4 2025 | 2025-12-31 | $1.8M | −$6.3M | −77.79% | +2.99% |
| Q3 2025 | 2025-09-30 | $1.7M | −$1.6M | −48.46% | +2.83% |
| Q2 2025 | 2025-06-30 | $7.0M | $3.8M | +115.30% | +12.37% |
| Q1 2025 | 2025-03-31 | −$13.4M | −$245,000 | — | −27.67% |
| Q4 2024 | 2024-12-31 | $8.1M | $9.7M | — | +16.32% |
| Q3 2024 | 2024-09-30 | $3.3M | $5.4M | — | +6.79% |
| Q2 2024 | 2024-06-30 | $3.3M | $7.4M | — | +6.79% |
| Q1 2024 | 2024-03-31 | −$13.2M | −$1.5M | — | −31.88% |
| Q4 2023 | 2023-12-31 | −$1.7M | $3.6M | — | −3.90% |
| Q3 2023 | 2023-09-30 | −$2.1M | $3.0M | — | −5.00% |
| Q2 2023 | 2023-06-30 | −$4.1M | $5.6M | — | −10.81% |
| Q1 2023 | 2023-03-31 | −$11.7M | $4.4M | — | −31.99% |
| Q4 2022 | 2022-12-31 | −$5.3M | $3.4M | — | −14.54% |
| Q3 2022 | 2022-09-30 | −$5.1M | $5.0M | — | −13.69% |
| Q2 2022 | 2022-06-30 | −$9.7M | −$1.2M | — | −28.26% |
| Q1 2022 | 2022-03-31 | −$16.1M | −$2.2M | — | −51.89% |
| Q4 2021 | 2021-12-31 | −$8.7M | −$8.5M | — | −27.54% |
| Q3 2021 | 2021-09-30 | −$10.1M | −$7.0M | — | −32.35% |
| Q2 2021 | 2021-06-30 | −$8.5M | $6.7M | — | −25.38% |
| Q1 2021 | 2021-03-31 | −$13.9M | −$842,000 | — | −44.83% |
| Q4 2020 | 2020-12-31 | −$161,000 | $4.2M | — | −0.50% |
| Q3 2020 | 2020-09-30 | −$3.1M | $749,000 | — | −9.29% |
| Q2 2020 | 2020-06-30 | −$15.2M | −$8.2M | — | −68.69% |
| Q1 2020 | 2020-03-31 | −$13.1M | −$3.7M | — | −53.88% |
| Q4 2019 | 2019-12-31 | −$4.3M | $888,000 | — | −15.33% |
| Q3 2019 | 2019-09-30 | −$3.9M | $4.5M | — | −13.50% |
| Q2 2019 | 2019-06-30 | −$7.0M | −$2.6M | — | −26.28% |
| Q1 2019 | 2019-03-31 | −$9.3M | −$3.1M | — | −40.13% |
| Q4 2018 | 2018-12-31 | −$5.2M | −$3.7M | — | −22.22% |
| Q3 2018 | 2018-09-30 | −$8.4M | −$6.0M | — | −36.91% |
| Q2 2018 | 2018-06-30 | −$4.4M | −$2.0M | — | −21.23% |
| Q1 2018 | 2018-03-31 | −$6.2M | −$2.2M | — | −35.94% |
| Q4 2017 | 2017-12-31 | −$1.5M | $235,922 | — | −9.06% |
| Q3 2017 | 2017-09-30 | −$2.4M | $121,037 | — | −15.03% |
| Q2 2017 | 2017-06-30 | −$2.3M | $508,480 | — | −15.44% |
| Q1 2017 | 2017-03-31 | −$4.1M | $959,561 | — | −33.11% |
| Q4 2016 | 2016-12-31 | −$1.8M | $2.5M | — | −15.54% |
| Q3 2016 | 2016-09-30 | −$2.5M | $467,750 | — | −22.60% |
| Q2 2016 | 2016-06-30 | −$2.9M | $773,009 | — | −27.46% |
| Q1 2016 | 2016-03-31 | −$5.0M | −$2.5M | — | −61.79% |
| Q4 2015 | 2015-12-31 | −$4.3M | −$1.7M | — | −55.29% |
| Q3 2015 | 2015-09-30 | −$3.0M | −$641,027 | — | −36.79% |
| Q2 2015 | 2015-06-30 | −$3.6M | −$966,041 | — | −56.46% |
| Q1 2015 | 2015-03-31 | −$2.5M | $826,069 | — | −50.90% |
| Q4 2014 | 2014-12-31 | −$2.6M | −$135,117 | — | −54.88% |
| Q3 2014 | 2014-09-30 | −$2.4M | $559,971 | — | −50.50% |
| Q2 2014 | 2014-06-30 | −$2.7M | −$125,542 | — | −63.06% |
| Q1 2014 | 2014-03-31 | −$3.3M | −$668,882 | — | −106.62% |
| Q4 2013 | 2013-12-31 | −$2.5M | $889,095 | — | −83.61% |
| Q3 2013 | 2013-09-30 | −$2.9M | −$1.1M | — | −98.69% |
| Q2 2013 | 2013-06-30 | −$2.5M | −$1.5M | — | −88.46% |
| Q1 2013 | 2013-03-31 | −$2.7M | −$169,591 | — | −124.93% |
| Q4 2012 | 2012-12-31 | −$3.4M | — | — | −165.52% |
| Q3 2012 | 2012-09-30 | −$1.8M | — | — | −92.40% |
| Q2 2012 | 2012-06-30 | −$987,715 | — | — | −49.08% |
| Q1 2012 | 2012-03-31 | −$2.5M | — | — | −151.66% |
Axogen free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$31.5M to −$2.9M, a net increase of $28.6M. Axogen's latest reported quarter, Q2 2026, generated $6.3M in free cash flow, a decrease of 9.70% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Axogen filings at SEC.gov ↗